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ABSTRACT
Carbamazepine is mainly used in the treatment of epilepsy, bipolar disorder and 
trigerminal neuralgia. However, it causes severe adverse drug reactions which include 
Steven Johnson Syndrome and/or Toxic Epidermal Necrolysis. Mechanisms leading to 
the adverse effects are hypothesised to involve production of reactive metabolites which 
deplete the antioxidant enzymes and therefore subjecting the individuals to oxidative 
stress. Hence, this study aims to determine the changes in the metabolism pathways 
involved in CBZ therapy which changes in the metabolite profiles of rats treated with 
different doses of CBZ were investigated and administration of tocotrienol rich fraction 
(TRF) were also studied to understand the potential roles of TRF in reducing the side 
effects of CBZ. Thirty-six (36) SD rats were used in this study. Three (3) different doses 
of CBZ, one (1) dose of CBZ+TRF and one (1) control (1 mL of normal saline) were 
given orally to 5 groups of SD rats. All sera and organs were collected after day 7,h of 
treatments. All samples were subjected to biochemical assays (liver function test, lipid 
peroxidation and antioxidant) and metabolomic analysis using LCMS-QTOF platform. 
Based on the metabolite profiling and metabolic pathway analysis, CBZ treated rats 
showed pertubation in the metabolism of four (4) metabolic pathways which include 
tryptophan, glutathione, purine and arginine-proline metabolism. These four (4) metabolic 
pathways in the treatment of CBZ which is related to the oxidative phosphorylation or 
oxidant-antioxidant balance system. On the other hand, TRF was found to have effects on 
the CBZ treated rats by restoring the antioxidant capacities via the four (4) major 
metabolic pathways mentioned above.
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